mnupal.mcgill.ca
Our Team
http://mnupal.mcgill.ca/index.php?option=com_content&task=blogcategory&id=16&Itemid=61
Antonio A.L. Vigano, MD, MSc. This e-mail address is being protected from spambots. You need JavaScript enabled to view it. This e-mail address is being protected from spambots. You need JavaScript enabled to view it " target=" self". Robert Kilgour, PhD, FACSM. This e-mail address is being protected from spambots. You need JavaScript enabled to view it. Prosanto Chaudhury, MD, CM, MSc, FRCSC, FACS. This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
mnupal.mcgill.ca
Our goals
http://mnupal.mcgill.ca/index.php?option=com_content&task=view&id=13&Itemid=1
In our quest to improve treatment of patients suffering from cachexia. Our research goals are:. Profile changes in body composition and body function associated with advanced cancer;. Identify biological substances or genetic characteristics which may be responsible for cancer-related loss of muscle, fat and function;. Determine the nutritional and functional measures that predict survival and treatment response after the diagnosis of incurable cancer;. Patients and Patients' Families.
maude.mcgill.ca
MAUDE unit
http://maude.mcgill.ca/index_fr.php
Soins cliniques et recherche. Lésions congénitales du coeur. Notre équipe de leaders et nos collaborateurs sont des spécialistes en soins cliniques et contribuent à l’avancement mondial des traitements pour les cardiopathies congénitales. Raquo; en savoir plus. L’histoire de l’Université McGill et de la cardiopathie congénitale est marquée de réalisations historiques, d’abord avec Maude Abbott et ses recherches cliniques dans les années trente. Raquo; en savoir plus. Raquo; en savoir plus.